Financial Gravity Asset Management, Inc. Pacific Biosciences Of California, Inc. Transaction History

Financial Gravity Asset Management, Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Jun 26, 2024	BUY	$3.52 - $9.59 $28 - $76	8 Added 160.0%	13 $48,000
Q1 2024 May 13, 2024	BUY	$3.52 - $9.59 $102 - $278	29 Added 580.0%	34 $128,000
Q4 2023 Jun 26, 2024	SELL	$5.97 - $10.36 $173 - $300	-29 Reduced 85.29%	5 $46,000
Q3 2023 Nov 15, 2023	SELL	$8.23 - $13.93 $65 - $111	-8 Reduced 61.54%	5 $0
Q2 2023 Aug 08, 2023	BUY	$9.97 - $14.05 $9 - $14	1 Added 8.33%	13 $289,000
Q1 2023 May 12, 2023	BUY	$7.94 - $12.02 $31 - $48	4 Added 50.0%	12 $8,000
Q4 2022 Feb 15, 2023	SELL	$5.67 - $11.2 $22 - $44	-4 Reduced 33.33%	8 $146,000
Q3 2022 Nov 03, 2022	BUY	$3.93 - $8.57 $15 - $34	4 Added 50.0%	12 $4,000
Q2 2022 Aug 05, 2022	SELL	$4.02 - $10.43 $40 - $104	-10 Reduced 55.56%	8 $3,000
Q1 2022 May 13, 2022	SELL	$8.43 - $20.9 $185 - $459	-22 Reduced 55.0%	18 $6,000
Q4 2021 Feb 11, 2022	BUY	$19.26 - $30.08 $751 - $1,173	39 Added 3900.0%	40 $14,000
Q2 2021 Aug 11, 2021	SELL	$22.3 - $36.02 $22 - $36	-1 Reduced 50.0%	1 $35,000
Q1 2021 May 17, 2021	BUY	$26.38 - $51.15 $52 - $102	2 New	2 $70,000

254

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $438M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Financial Gravity Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Financial Gravity Asset Management, Inc. with notifications on news.